Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Эндометриоидная аденокарцинома при беременности: клинический случай
Мусина Е.В., Траль Т.Г., Тарасова М.А. Эндометриоидная аденокарцинома при беременности: клинический случай. Гинекология. 2016; 18 (2): 81–83.
________________________________________________
Musina E.V., Tral T.G., Tarasova M.A. Еndometrioid adenocarcinoma in pregnancy: case report. Gynecology. 2016; 18 (2): 81–83.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Злокачественные опухоли при беременности встречаются в 0,07–0,1% случаев от числа всех беременностей. Эндометриоидная аденокрацинома является крайне редкой патологией при беременности. Однако существует актуальность онкологической настороженности в отношении эндометриоидной аденокарциномы у женщин репродуктивного возраста, в том числе на фоне беременности.
Ключевые слова: эндометриоидная аденокарцинома, беременность.
Ключевые слова: эндометриоидная аденокарцинома, беременность.
________________________________________________
Malignant tumors are encountered in pregnancy in cases of 0.07–0.1% of all pregnancies. Endometriod adenokratsinoma is an extremely rare disease in pregnancy. However there is the urgency of oncological vigilance against endometrial adenocarcinoma in women of reproductive age, including the background of pregnancy.
Key words: endometrioid adenocarcinoma, pregnancy.
Полный текст
Список литературы
1. Mitamura T, Watari H, Todo Y et al. A 14-year-old female patient with FIGO stage IB endometrial carcinoma: a case report. Int J Gynecol Cancer 2009; 19: 896–7.
2. Gusberg SB. Estrogen and endometrial cancer: an epilogue la recherche du temps perdu. Gynecol Oncol 1994; 52: 3–9.
3. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012; 27: 1327–31.
4. Gottschau M et al. Risk of cancer among women with polycystic ovary syndrome. Gynecol Oncol 2015; 136: 99–103.
5. Gregory CW et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clinl Endocrinol Metab 2002; 87 (6): 2960–6.
6. Maliqueo M et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003; 80 (2): 812–9.
7. Quezada S et al. Evalution of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometrial from untreated women with polycystic ovary syndrome. Fertil Steril 2006; 85 (4): 1017–26.
8. Villavicencio A et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovary syndrome with and without endometrial hyperplasia. Gynecol Obstet 2006; 103 (1): 307–14.
9. Avellaira C et al. Expression of molecules associated with tissue homeostasis in secretory endometrial from untreated women with polycystic ovary syndrome. Hum Reprod 2006; 21 (12): 311–21.
10. Chen Y et al. Expression of apoptosis regulatoryprotein bcl-2 and bax in endometrium of polycystic ovary syndrome. Chinese J Obstet Gynecol 1999; 34 (11): 652–4.
11. Xin Li et al. Endometrial progesterone resistance and PCOS. J Biomed Sci 2014; 21 (1): 2.
12. Завалишина Л.Э., Франк Г.А., Андреева Ю.Ю. Уточняющая диагностика при раках некоторых локализаций с использованием иммуногистохимических маркеров. Практич. пособие. М., 2006. / Zavalishina L.E., Frank G.A., Andreeva Iu.Iu. Utochniaiushchaia diagnostika pri rakakh nekotorykh lokalizatsii s ispol'zovaniem immunogistokhimicheskikh markerov. Praktich. posobie. M., 2006. [in Russian]
13. Киселев В.И., Ляшеко А.А. Молекулярные механизмы регуляции гиперпластических процессов. М.: Димитрейд График Групп, 2005. / Kiselev V.I., Liasheko A.A. Molekuliarnye mekhanizmy reguliatsii giperplasticheskikh protsessov. M.: Dimitreid Grafik Grupp, 2005. [in Russian]
14. Пальцев М.А., Иванов А.А. Межклеточные взаимодействия. М.: Медицина, 1995. / Pal'tsev M.A., Ivanov A.A. Mezhkletochnye vzaimodeistviia. M.: Meditsina, 1995. [in Russian]
15. Биохимические основы патологических процессов. Под ред. Е.С.Северина. М.: Медицина, 2000. / Biokhimicheskie osnovy patologicheskikh protsessov. Pod red. E.S.Severina. M.: Meditsina, 2000. [in Russian]
16. Табакман Ю.Ю. Рак эндометрия. Руководство для врачей. М.: Практическая медицина, 2009. / Tabakman Iu.Iu. Rak endometriia. Rukovodstvo dlia vrachei. M.: Prakticheskaia meditsina, 2009. [in Russian]
17. American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
2. Gusberg SB. Estrogen and endometrial cancer: an epilogue la recherche du temps perdu. Gynecol Oncol 1994; 52: 3–9.
3. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012; 27: 1327–31.
4. Gottschau M et al. Risk of cancer among women with polycystic ovary syndrome. Gynecol Oncol 2015; 136: 99–103.
5. Gregory CW et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clinl Endocrinol Metab 2002; 87 (6): 2960–6.
6. Maliqueo M et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003; 80 (2): 812–9.
7. Quezada S et al. Evalution of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometrial from untreated women with polycystic ovary syndrome. Fertil Steril 2006; 85 (4): 1017–26.
8. Villavicencio A et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovary syndrome with and without endometrial hyperplasia. Gynecol Obstet 2006; 103 (1): 307–14.
9. Avellaira C et al. Expression of molecules associated with tissue homeostasis in secretory endometrial from untreated women with polycystic ovary syndrome. Hum Reprod 2006; 21 (12): 311–21.
10. Chen Y et al. Expression of apoptosis regulatoryprotein bcl-2 and bax in endometrium of polycystic ovary syndrome. Chinese J Obstet Gynecol 1999; 34 (11): 652–4.
11. Xin Li et al. Endometrial progesterone resistance and PCOS. J Biomed Sci 2014; 21 (1): 2.
12. Завалишина Л.Э., Франк Г.А., Андреева Ю.Ю. Уточняющая диагностика при раках некоторых локализаций с использованием иммуногистохимических маркеров. Практич. пособие. М., 2006. / Zavalishina L.E., Frank G.A., Andreeva Iu.Iu. Utochniaiushchaia diagnostika pri rakakh nekotorykh lokalizatsii s ispol'zovaniem immunogistokhimicheskikh markerov. Praktich. posobie. M., 2006. [in Russian]
13. Киселев В.И., Ляшеко А.А. Молекулярные механизмы регуляции гиперпластических процессов. М.: Димитрейд График Групп, 2005. / Kiselev V.I., Liasheko A.A. Molekuliarnye mekhanizmy reguliatsii giperplasticheskikh protsessov. M.: Dimitreid Grafik Grupp, 2005. [in Russian]
14. Пальцев М.А., Иванов А.А. Межклеточные взаимодействия. М.: Медицина, 1995. / Pal'tsev M.A., Ivanov A.A. Mezhkletochnye vzaimodeistviia. M.: Meditsina, 1995. [in Russian]
15. Биохимические основы патологических процессов. Под ред. Е.С.Северина. М.: Медицина, 2000. / Biokhimicheskie osnovy patologicheskikh protsessov. Pod red. E.S.Severina. M.: Meditsina, 2000. [in Russian]
16. Табакман Ю.Ю. Рак эндометрия. Руководство для врачей. М.: Практическая медицина, 2009. / Tabakman Iu.Iu. Rak endometriia. Rukovodstvo dlia vrachei. M.: Prakticheskaia meditsina, 2009. [in Russian]
17. American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
________________________________________________
1. Mitamura T, Watari H, Todo Y et al. A 14-year-old female patient with FIGO stage IB endometrial carcinoma: a case report. Int J Gynecol Cancer 2009; 19: 896–7.
2. Gusberg SB. Estrogen and endometrial cancer: an epilogue la recherche du temps perdu. Gynecol Oncol 1994; 52: 3–9.
3. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012; 27: 1327–31.
4. Gottschau M et al. Risk of cancer among women with polycystic ovary syndrome. Gynecol Oncol 2015; 136: 99–103.
5. Gregory CW et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clinl Endocrinol Metab 2002; 87 (6): 2960–6.
6. Maliqueo M et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003; 80 (2): 812–9.
7. Quezada S et al. Evalution of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometrial from untreated women with polycystic ovary syndrome. Fertil Steril 2006; 85 (4): 1017–26.
8. Villavicencio A et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovary syndrome with and without endometrial hyperplasia. Gynecol Obstet 2006; 103 (1): 307–14.
9. Avellaira C et al. Expression of molecules associated with tissue homeostasis in secretory endometrial from untreated women with polycystic ovary syndrome. Hum Reprod 2006; 21 (12): 311–21.
10. Chen Y et al. Expression of apoptosis regulatoryprotein bcl-2 and bax in endometrium of polycystic ovary syndrome. Chinese J Obstet Gynecol 1999; 34 (11): 652–4.
11. Xin Li et al. Endometrial progesterone resistance and PCOS. J Biomed Sci 2014; 21 (1): 2.
12. Zavalishina L.E., Frank G.A., Andreeva Iu.Iu. Utochniaiushchaia diagnostika pri rakakh nekotorykh lokalizatsii s ispol'zovaniem immunogistokhimicheskikh markerov. Praktich. posobie. M., 2006. [in Russian]
13. Kiselev V.I., Liasheko A.A. Molekuliarnye mekhanizmy reguliatsii giperplasticheskikh protsessov. M.: Dimitreid Grafik Grupp, 2005. [in Russian]
14. Pal'tsev M.A., Ivanov A.A. Mezhkletochnye vzaimodeistviia. M.: Meditsina, 1995. [in Russian]
15. Biokhimicheskie osnovy patologicheskikh protsessov. Pod red. E.S.Severina. M.: Meditsina, 2000. [in Russian]
16. Tabakman Iu.Iu. Rak endometriia. Rukovodstvo dlia vrachei. M.: Prakticheskaia meditsina, 2009. [in Russian]
17. American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
Авторы
Е.В.Мусина*, Т.Г.Траль, М.А.Тарасова
ФГБНУ НИИ акушерства, гинекологии и репродуктологии им. Д.О.Отта. 199034, Россия, Санкт-Петербург, Менделеевская линия, д. 3
*e.musina@mail.ru
ФГБНУ НИИ акушерства, гинекологии и репродуктологии им. Д.О.Отта. 199034, Россия, Санкт-Петербург, Менделеевская линия, д. 3
*e.musina@mail.ru
________________________________________________
E.V.Musina*, T.G.Tral, M.A.Tarasova
D.O.Ott Research Institute of Obstetrics, Gynecology and Reproduction. 199034, Russian Federation, Saint Petersburg, Mendeleevskaia liniia, d. 3
*e.musina@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.